- Seeking Alpha2026. 07. 18. 01:14
Armata Pharmaceuticals: Promising Phage Platform, But Phase 3 Is Everything (NYSE:ARMP) - Seeking Alpha
Armata Pharmaceuticals: Promising Phage Platform, But Phase 3 Is Everything (NYSE:ARMP) Seeking Alpha
- Investing.com Nigeria2026. 07. 15. 09:51
Form 4 Armata Pharmaceuticals Inc For: 14 July By Investing.com - Investing.com Nigeria
Form 4 Armata Pharmaceuticals Inc For: 14 July By Investing.com Investing.com Nigeria
- TipRanks2026. 07. 14. 13:14
Armata Pharmaceuticals reaches agreement with FDA on iPSP for AP-SA02 - TipRanks
Armata Pharmaceuticals reaches agreement with FDA on iPSP for AP-SA02 TipRanks
- TipRanks2026. 07. 13. 22:38
FDA Pediatric Plan Milestone and Phase 3 Design Support Unchanged $15 Price Target and Buy Rating on Armata (ARMP) - TipRanks
FDA Pediatric Plan Milestone and Phase 3 Design Support Unchanged $15 Price Target and Buy Rating on Armata (ARMP) TipRanks
- MT Newswires2026. 07. 13. 20:47
Armata Pharma Reaches FDA Agreement on Pediatric Study Plan for AP-SA02
- PR Newswire2026. 07. 13. 20:00
Armata Pharmaceuticals Receives Agreement from FDA on Initial Pediatric Study Plan for AP-SA02 for the Treatment of Complicated Staphylococcus aureus Bacteremia
